These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37876983)

  • 21. Honokiol, a constituent of Magnolia species, inhibits adrenergic contraction of human prostate strips and induces stromal cell death.
    Herrmann D; Schreiber A; Ciotkowska A; Strittmatter F; Waidelich R; Stief CG; Gratzke C; Hennenberg M
    Prostate Int; 2014 Sep; 2(3):140-6. PubMed ID: 25325026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isoform-independent promotion of contractility and proliferation, and suppression of survival by with no lysine/K kinases in prostate stromal cells.
    Liu Y; Huang R; Wang R; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
    FASEB J; 2024 Apr; 38(7):e23604. PubMed ID: 38591106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of isocorynoxeine, from Uncaria, on lower urinary tract dysfunction caused by benign prostatic hyperplasia via antagonism of α
    Li T; Xu K; He J; Jahan N; Song J; Wang S
    Toxicol Appl Pharmacol; 2019 Aug; 376():95-106. PubMed ID: 31145917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume.
    Xia BW; Zhao SC; Chen ZP; Chen C; Liu TS; Yang F; Yan Y
    Prostate; 2020 May; 80(6):481-490. PubMed ID: 32104919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Adrenergic and Non-Adrenergic Smooth Muscle Contraction in the Human Prostate by the Phosphodiesterase 10-Selective Inhibitor TC-E 5005.
    Hennenberg M; Schott M; Kan A; Keller P; Tamalunas A; Ciotkowska A; Rutz B; Wang Y; Strittmatter F; Herlemann A; Yu Q; Stief CG; Gratzke C
    Prostate; 2016 Nov; 76(15):1364-74. PubMed ID: 27418235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of carvedilol on human prostate tissue contractility and stromal cell growth pointing to potential clinical implications.
    Hu S; Müderrisoglu AE; Ciotkowska A; Kale O; Keller P; Schott M; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
    Pharmacol Rep; 2024 Aug; 76(4):807-822. PubMed ID: 38858312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of neurogenic and thromboxane A
    Li B; Wang X; Wang R; Rutz B; Ciotkowska A; Gratzke C; Herlemann A; Spek A; Tamalunas A; Waidelich R; Stief CG; Hennenberg M
    Prostate; 2020 Aug; 80(11):831-849. PubMed ID: 32449814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of agonist-induced smooth muscle contraction by picotamide in the male human lower urinary tract outflow region.
    Hennenberg M; Tamalunas A; Wang Y; Keller P; Schott M; Strittmatter F; Herlemann A; Yu Q; Rutz B; Ciotkowska A; Stief CG; Gratzke C
    Eur J Pharmacol; 2017 May; 803():39-47. PubMed ID: 28315343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S100A4 modulates cell proliferation, apoptosis and fibrosis in the hyperplastic prostate.
    Yang L; Liu J; Yin J; Li Y; Liu J; Liu D; Wang Z; DiSanto ME; Zhang W; Zhang X
    Int J Biochem Cell Biol; 2024 Apr; 169():106551. PubMed ID: 38360265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective inhibition of neurogenic, but not agonist-induced contractions by phospholipase A
    Hu S; Huang R; Keller P; Götz M; Tamalunas A; Weinhold P; Waidelich R; Stief CG; Hennenberg M
    Neurourol Urodyn; 2023 Sep; 42(7):1522-1531. PubMed ID: 37583250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of prostatic smooth muscle contraction by the inhibitor of G protein-coupled receptor kinase 2/3, CMPD101.
    Yu Q; Gratzke C; Wang Y; Herlemann A; Strittmatter F; Rutz B; Stief CG; Hennenberg M
    Eur J Pharmacol; 2018 Jul; 831():9-19. PubMed ID: 29698717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of Prostate Smooth Muscle Contraction by Inhibitors of Polo-Like Kinases.
    Hennenberg M; Kuppermann P; Yu Q; Herlemann A; Tamalunas A; Wang Y; Rutz B; Ciotkowska A; Strittmatter F; Stief CG; Gratzke C
    Front Physiol; 2018; 9():734. PubMed ID: 29962965
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of alpha1-adrenoceptor antagonists on cultured prostatic smooth muscle cells.
    Boesch ST; Dobler G; Ramoner R; Corvin S; Thurnher M; Bartsch G; Klocker H
    Prostate Suppl; 2000; 9():34-41. PubMed ID: 11056501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-Adrenergic, Tamsulosin-Insensitive Smooth Muscle Contraction is Sufficient to Replace α
    Hennenberg M; Acevedo A; Wiemer N; Kan A; Tamalunas A; Wang Y; Yu Q; Rutz B; Ciotkowska A; Herlemann A; Strittmatter F; Stief CG; Gratzke C
    Prostate; 2017 May; 77(7):697-707. PubMed ID: 28116771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.
    Nicholson TM; Sehgal PD; Drew SA; Huang W; Ricke WA
    Differentiation; 2013; 85(4-5):140-9. PubMed ID: 23792768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tadalafil enhances the inhibitory effects of tamsulosin on neurogenic contractions of human prostate and bladder neck.
    Angulo J; Cuevas P; Fernández A; La Fuente JM; Allona A; Moncada I; Sáenz de Tejada I
    J Sex Med; 2012 Sep; 9(9):2293-306. PubMed ID: 22759598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.
    Popovics P; Awadallah WN; Kohrt SE; Case TC; Miller NL; Ricke EA; Huang W; Ramirez-Solano M; Liu Q; Vezina CM; Matusik RJ; Ricke WA; Grabowska MM
    Prostate; 2020 Jul; 80(10):731-741. PubMed ID: 32356572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive patient evaluation for benign prostatic hyperplasia.
    Jepsen JV; Bruskewitz RC
    Urology; 1998 Apr; 51(4A Suppl):13-8. PubMed ID: 9586591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Breyer BN; Huang WY; Rabkin CS; Alderete JF; Pakpahan R; Beason TS; Kenfield SA; Mabie J; Ragard L; Wolin KY; Grubb RL; Andriole GL; Sutcliffe S
    BJU Int; 2016 Jan; 117(1):145-54. PubMed ID: 25601300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
    Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
    Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.